Myasthenia gravis
Myasthenia gravis (MG) is an autoimmune disease with conduction disorders at the skeletal muscle neuromuscular junction. It is characterized by muscle fatigue that is mild in the morning and severe in the evening, and is relieved after rest or taking cholinesterase inhibitors. It often affects the extraocular muscles, masticatory muscles, swallowing muscles, and respiratory muscles. In severe cases, the bulbar palsy occurs. The distribution of affected muscles varies from person to person and from time to time, and it is not a paralysis that occurs when a certain nerve is damaged. This disease should be called acquired autoimmune myasthenia gravis, usually referred to as myasthenia gravis.
-
Site of disease:
immune system muscle whole body -
Infectious :
Not contagious -
Frequent population:
It is more common in children, with onset between 20 and 40 years old... -
Related symptoms:
Weakness Eyelid drooping Facial muscle weakness Fatigue Difficulty swallowing -
Concurrent disease:
Related Drugs
Shenqi Granules
Manufacturer:
Sunflower Pharmaceutical Group Chongqing Xiaokuihua Children's Pharmaceutical Co., Ltd.
Guogong Liquor
Manufacturer:
Beijing Tongrentang Co., Ltd. Tongrentang Medicinal Wine Factory
Jixiang Ankunwan
Manufacturer:
Inne Mongolia Kulun Medicine Co., Ltd.
Yi'anning Pills
Manufacturer:
Tongyitang Pharmaceutical Co., Ltd.
Neostigmine Methylsulfate Injection
Indication: Anticholinesterase drugs. Used to antagonize the residual muscle relaxant effect of non-depolarizing muscle relaxants at the end of surgery, and used for myasthenia gravis, postoperative functional intestinal flatulence and urinary retention, etc.
Manufacturer:
Shanghai Sine Jinzhu Pharmacy Co., Ltd.
Neostigmine Methylsulfate Injection
Indication: Anticholinesterase drugs. Used to antagonize the residual muscle relaxant effect of non-depolarizing muscle relaxants at the end of surgery, and used for myasthenia gravis, postoperative functional intestinal flatulence and urinary retention, etc.
Manufacturer:
Jiangsu Pujin Pharmaceutical Co., Ltd.
Neostigmine Methylsulfate Injection
Indication: Anticholinesterase drugs. Used to antagonize the residual muscle relaxant effect of non-depolarizing muscle relaxants at the end of surgery, and used for myasthenia gravis, postoperative functional intestinal flatulence and urinary retention, etc.
Manufacturer:
Henan Runhong Pharmaceutical Co., Ltd.
Neostigmine Methylsulfate Injection
Indication: Anticholinesterase drugs. Used to antagonize the residual muscle relaxant effect of non-depolarizing muscle relaxants at the end of surgery, and used for myasthenia gravis, postoperative functional intestinal flatulence and urinary retention, etc.
Manufacturer:
Jiangsu Pujin Pharmaceutical Co., Ltd.
Neostigmine Methylsulfate Injection
Indication: Anticholinesterase drugs. Used to antagonize the residual muscle relaxant effect of non-depolarizing muscle relaxants at the end of surgery, and used for myasthenia gravis, postoperative functional intestinal flatulence and urinary retention, etc.
Manufacturer:
Zhejiang Xianju Pharmaceutical Co., Ltd.
Compound Licorice and Fritillary Ammonium Chloride Tablets
Indication: For patients with myasthenia gravis who cannot tolerate neostigmine, pyridostigmine or are allergic to bromine, the dose should be adjusted according to the patient's efficacy.
Manufacturer:
Zhejiang Conba Pharmaceutical Co., Ltd.
Related Ingredients
-
Sea buckthorn, Hippophae rhamnoides, ext. list
90106-68-6 -
Mercury(II) sulfide list
1344-48-5 -
Atificial Cow-bezoar list
1002-00-2 -
Anise oil list
8007-70-3 -
Neostigmine Methyl Sulfate list
51-60-5